Filter Results
:
(239)
Show Results For
-
All HBS Web
(635)
- Faculty Publications (239)
Show Results For
-
All HBS Web
(635)
- Faculty Publications (239)
- November 1999
- Case
Seminis Inc.
By: Ray A. Goldberg, Jonathan West, Carin-Isabel Knoop and David Benedict Pearcy
Seminis became the world leader in vegetable seeds through a series of acquisitions. This case describes the Seminis strategy toward capturing value, biotechnology, and international operations.
View Details
Keywords:
Business Earnings;
Acquisition;
Profit;
Global Strategy;
Corporate Strategy;
Valuation;
Value Creation;
Biotechnology Industry
Goldberg, Ray A., Jonathan West, Carin-Isabel Knoop, and David Benedict Pearcy. "Seminis Inc." Harvard Business School Case 600-030, November 1999.
- October 1999
- Case
Agricultural Biotechnology Brief, 1999
By: Forest L. Reinhardt and Jennifer Burns
Keywords:
Business and Government Relations;
Environmental Sustainability;
Biotechnology Industry;
Biotechnology Industry
Reinhardt, Forest L., and Jennifer Burns. "Agricultural Biotechnology Brief, 1999." Harvard Business School Case 700-066, October 1999.
- May 1999
- Teaching Note
Elliot Lebowitz TN
By: Paul A. Gompers
Teaching Note for (9-297-094).
View Details
Keywords:
Biotechnology Industry
- May 1999
- Teaching Note
Genset Initial Public Offering (A) & (B) TN
By: Paul A. Gompers
Teaching Note for (9-297-096) and (9-297-097).
View Details
- May 1999
- Teaching Note
Genset: 1989 TN
By: Paul A. Gompers
Teaching Note for (9-298-070).
View Details
- October 1998 (Revised December 1999)
- Case
Gene Research, the Mapping of Life and the Global Economy
By: Ray A. Goldberg and Juan Enriquez-Cabot
A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one...
View Details
Keywords:
Information Technology;
Organizational Structure;
Technological Innovation;
Business Processes;
Health Care and Treatment;
Performance Productivity;
Welfare;
Agribusiness;
Genetics;
Science-Based Business;
Biotechnology Industry;
Biotechnology Industry
Goldberg, Ray A., and Juan Enriquez-Cabot. "Gene Research, the Mapping of Life and the Global Economy." Harvard Business School Case 599-016, October 1998. (Revised December 1999.)
- September 1998
- Case
Monsanto's March into Biotechnology (C)
By: Dorothy A. Leonard and Robert Irwin
Supplements the (A) and (B) cases.
View Details
Leonard, Dorothy A., and Robert Irwin. "Monsanto's March into Biotechnology (C)." Harvard Business School Case 699-021, September 1998.
- Article
The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry
By: Josh Lerner and Robert P. Merges
Lerner, Josh, and Robert P. Merges. "The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry." Journal of Industrial Economics 46, no. 2 (June 1998): 125–156. (Special Symposium "Inside the Pin Factory": Empirical Studies Augmented by Manager Interviews.)
- January 1998 (Revised September 2001)
- Case
Genset: 1989
By: Paul A. Gompers and Amy Burroughs
Discusses the start-up strategy at Genset, a French biotech firm. Pascal Brandys, a venture capitalist, and Marc Vasseur, a leading French scientist, must decide how to proceed. Future real options are central to the strategy.
View Details
Gompers, Paul A., and Amy Burroughs. "Genset: 1989." Harvard Business School Case 298-070, January 1998. (Revised September 2001.)
- October 1997
- Case
Roslin Institute, The
By: Ray A. Goldberg and Tom Clay
Dr. Ian Willmut and the Roslin Institute have developed a revolutionary new technology--cloning. Now they are faced with some tough choices concerning going forward. How should they balance commercialization opportunities with societal concerns?
View Details
Keywords:
Decision Choices and Conditions;
Independent Innovation and Invention;
Social Issues;
Commercialization;
Biotechnology Industry
Goldberg, Ray A., and Tom Clay. "Roslin Institute, The." Harvard Business School Case 598-045, October 1997.
- September 1997 (Revised October 1997)
- Case
Bayer AG (A)
By: John A. Quelch
Bayer's senior executives convene in Germany to consider submitting a $1 billion bid that would recover the Bayer brand name and trademark cross in North America, both of which were confiscated by the U.S. government after World War I. The group also sets out to assess...
View Details
Keywords:
Management Teams;
Brands and Branding;
War;
Communication;
Trademarks;
Acquisition;
Government and Politics;
Biotechnology Industry;
Biotechnology Industry;
Germany;
North America;
United States
Quelch, John A., and Robin Root. "Bayer AG (A)." Harvard Business School Case 598-031, September 1997. (Revised October 1997.)
- September 1997
- Case
Bayer AG (B)
By: John A. Quelch
Bayer's senior executives detail the communications challenge program that resulted from the company's reacquisition of its brand name and trademark cross, which gave Bayer one name worldwide for the first time since World War I.
View Details
Keywords:
Globalized Firms and Management;
War;
Acquisition;
Trademarks;
Brands and Branding;
Communication Strategy;
Biotechnology Industry;
Biotechnology Industry;
Germany
Quelch, John A., and Robin Root. "Bayer AG (B)." Harvard Business School Case 598-032, September 1997.
- June 1997 (Revised October 2001)
- Case
Elliot Lebowitz
By: Paul A. Gompers and Alexander Tsai
Elliot Lebowitz, president and CEO of BioTransplant, must decide on a strategy for this young biotechnology start-up. Among the issues to be resolved are focus of research and search for strategic alliance partners.
View Details
Keywords:
Alliances;
Research;
Business Startups;
Management Teams;
Business Strategy;
Biotechnology Industry;
United States
Gompers, Paul A., and Alexander Tsai. "Elliot Lebowitz." Harvard Business School Case 297-094, June 1997. (Revised October 2001.)
- June 1997 (Revised March 2001)
- Case
Genset Initial Public Offering (A)
By: Paul A. Gompers and Jeffrey M. Anapolsky
Pascal Brandys, founder and CEO of Genset, must decide whether to take this young biotechnology company public. If so, should he do a dual offering in both France and the U.S.? The case also explores the business models in genomics research.
View Details
Keywords:
Business Model;
Initial Public Offering;
Genetics;
Going Public;
Management Teams;
Biotechnology Industry;
France;
United States
Gompers, Paul A., and Jeffrey M. Anapolsky. "Genset Initial Public Offering (A)." Harvard Business School Case 297-096, June 1997. (Revised March 2001.)
- June 1997 (Revised September 1997)
- Case
Genset Initial Public Offering (B)
By: Paul A. Gompers and Jeffrey M. Anapolsky
Supplements the (A) case.
View Details
Keywords:
Business Model;
Initial Public Offering;
Genetics;
Going Public;
Management Teams;
Biotechnology Industry;
France;
United States
Gompers, Paul A., and Jeffrey M. Anapolsky. "Genset Initial Public Offering (B)." Harvard Business School Case 297-097, June 1997. (Revised September 1997.)
- March 1997
- Case
BioTransplant, Inc.: Initial Public Offering, January 1996
By: Paul A. Gompers and Alexander Tsai
Examines the decision to go public. BioTransplant is an early stage biotechnology company that must decide how to finance its research and development. The pros and cons of public offerings are analyzed versus alternative financing sources.
View Details
Gompers, Paul A., and Alexander Tsai. "BioTransplant, Inc.: Initial Public Offering, January 1996." Harvard Business School Case 297-095, March 1997.
- 1997
- Chapter
Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond
By: Josh Lerner and Robert P. Merges
Keywords:
Patents;
Applications and Software;
Genetics;
Biotechnology Industry;
Biotechnology Industry
Lerner, Josh, and Robert P. Merges. "Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond." In Competing in the Age of Digital Convergence, edited by D. B. Yoffie, 301–324. Boston: Harvard Business School Press, 1997.
- August 1996 (Revised May 1997)
- Case
Delta & Pine Land: Measuring the Value of Transgenic Cotton
By: Ray A. Goldberg and Charlotte A. Tasker
Discusses the joint venture between two companies with different capabilities: 1) technology provider and 2) transportation agent. Discusses how to capture value from joint venture and biotechnology: 1) who are winners and who are losers; 2) how much value can/should...
View Details
Keywords:
Agribusiness;
Joint Ventures;
Marketing Strategy;
Supply Chain Management;
Performance Consistency;
Information Technology;
Transportation;
Valuation;
Biotechnology Industry
Goldberg, Ray A., and Charlotte A. Tasker. "Delta & Pine Land: Measuring the Value of Transgenic Cotton." Harvard Business School Case 597-005, August 1996. (Revised May 1997.)
- January 1996
- Case
Biogen, Inc.: rBeta Interferon Manufacturing Process Development
Biogen, Inc., a Cambridge, MA-based biotechnology company, is wrapping up a project to develop a new manufacturing process for a new drug product that will reposition the company from a purely research-oriented company to a fully integrated pharmaceutical manufacturing...
View Details
Keywords:
Learning;
Technological Innovation;
Management Analysis, Tools, and Techniques;
Product Development;
Organizational Change and Adaptation;
Projects;
Research and Development;
Corporate Strategy;
Biotechnology Industry
Wheelwright, Steven C. "Biogen, Inc.: rBeta Interferon Manufacturing Process Development." Harvard Business School Case 696-083, January 1996.